Integra Lifesciences Holdings Corp at JPMorgan Healthcare Conference Transcript
Get started here. I'm Robbie Marcus, the med tech analyst at JPMorgan. Really happy to introduce the CEO of Integra, Jan De Witte. Jan will do the presentation, then we'll do some Q&A after.
Perfect. Thank you, Robbie. I'm Jan De Witte, the CEO of Integra LifeSciences. With me here is Lea Knight, our CFO. Together, we'll cover with Rob the Q&A.
First things first, our safe harbor disclosure. As a reminder that some comments during this presentation are going to be forward-looking. So let's get started. I know many of you, when I look through the room, have been following Integra for many years. Also see quite a number of new faces and I hope that we have more on the webcast that don't know us that well. And I hope that you will come away as excited as we are as a management team about Integra's future opportunities. And so I'm going to take a bit of time taking us through the
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
